Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

计划入组 30 人 · 首次发布于 2023 年 4 月 5 日

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

计划入组 34 人 · 首次发布于 2019 年 4 月 1 日

BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites)

计划入组 56 人 · 首次发布于 2021 年 12 月 30 日

rTAP (Merck Sharpe and Dohme)

Antistasin(Merck Sharp & Dohme Corp.)

MK-8583 (Merck Sharp & Dohme)

Merck Sharp & Dohme Corp

Chile

Merck Sharp & Dohme Corp.

United States

Merck Sharp & Dohme BV

Netherlands

Artiva Biotherapeutics Announces AlloNK® Clinical Updates and Q3 2024 Financial Results

Glenmark Pharmaceuticals Reaches $7M Settlement in US Antitrust Lawsuits Over Cholesterol Drugs

Immunotherapy Drug Shows Potential to Cure Advanced Lung Cancer